Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC [Phase 2]
Phase 2 trial evaluating checkpoint inhibition with chemoradiotherapy as a bladder-sparing approach for urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for intravenous vitamin C combined with chemotherapy in cisplatin-ineligible bladder ca…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer [Phase 2]
Phase 2 trial update evaluating ICP-192 for efficacy and safety in bladder urothelial cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study [Phase 2]
Phase 2 trial evaluating avelumab as a single agent in metastatic or locally advanced urothelial cancer in patients unfit for cisplatin has …
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial assessing acupuncture for treating adverse events related to intravesical BCG in high-risk non-muscle invasive bladde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Radiogenomics of Muscle Invasive Bladder Cancer [NA]
A terminated clinical trial study on radiogenomics in muscle invasive bladder cancer was conducted; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies [Phase 1, Phase 2]
A dose-finding and safety study of an oral single-agent therapy for advanced solid tumors, including metastatic bladder cancer, completed wi…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol [Phase 3]
Phase 3 clinical trial comparing alvimopan to placebo in bladder cancer patients undergoing radical cystectomy under an enhanced recovery pr…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of Pseudomonas aeruginosa for intermediate and high-risk non-muscle invasive bl…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer [Phase 2]
Phase 2 trial evaluating durvalumab in combination with standard chemotherapy before surgery for variant histology bladder cancers; study te…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update of cadonilimab plus nab-paclitaxel for recurrent or metastatic muscle-invasive bladder cancer (bladder cancer).
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer [NA]
Clinical trial update for a checkpoint inhibitor with radiation in bulky, node-positive bladder cancer; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Evaluation of NanoDoce® in Participants With Urothelial Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating NanoDoce® in urothelial carcinoma and bladder cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer [Phase 3]
Phase 3 clinical trial evaluating BCG with or without gefitinib in high-risk bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG [Phase 3]
Phase 3 trial update for Vicinium in non-muscle invasive bladder cancer previously treated with BCG has completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [Phase 3]
Phase 3 trial comparing two-drug vs four-drug chemotherapy regimens in advanced urothelial cancer (bladder cancer and related urothelial can…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure [Phase 2]
Phase 2 trial evaluating intravesical electromotive delivery of mitomycin after BCG failure in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating pemetrexed disodium and gemcitabine in advanced urothelial cancers (bladder cancer and transitional cell cancers of…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Chemotherapy in Treating Patients With Early-Stage Bladder Cancer [Phase 2]
Phase 2 clinical trial update on using chemotherapy to treat patients with early-stage bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for advanced urothelial cancer with decreased kidney function has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
Phase 2 clinical trial evaluating piritrexim in advanced urinary tract cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer [Phase 3]
A Phase 3 trial evaluating the addition of mitomycin to BCG as adjuvant intravesical therapy for high-risk non-muscle-invasive bladder cance…